SCHEMBL17704026

SCHEMBL17704026

CC1(C)c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)ccc2Oc2ccc(-c3ccc4c(c3)c3cc(C#N)ccc3n4-c3ccccc3)cc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MYC P01106 2/20 0.41
▸ ABCC9 O60706 5/20 0.37
▸ ALDH1A3 P47895 2/20 0.34
▸ GABRA1 P14867 2/20 0.33
▸ GABRG2 P18507 2/20 0.33
▸ GABRB3 P28472 2/20 0.33
▸ GABRA5 P31644 2/20 0.33
▸ GABRA3 P34903 2/20 0.33
▸ JAK2 O60674 1/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ ABL1 P00519 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ ERBB2 P04626 1/20 0.33
▸ LCK P06239 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ LYN P07948 1/20 0.33
▸ RET P07949 1/20 0.33
▸ KIT P10721 1/20 0.33
▸ FGFR1 P11362 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17704023 0.98 MYC (0.41) MYCABCC9ALDH1A3GABRA1GABRG2
SCHEMBL17704022 0.94 ABCC9 (0.35) MYCABCC9ALDH1A3JAK2PRKD3
SCHEMBL17704024 0.93 ABCG2 (0.36) MYCABCC9ALDH1A3JAK2PRKD3
SCHEMBL17703195 0.92 MYC (0.41) MYCABCC9ALDH1A3GABRA1GABRG2
SCHEMBL17703991 0.91 CYP1A2 (0.36) ABCC9ALDH1A3CLK4PGRCTSD
SCHEMBL17704041 0.90 MYC (0.40) MYCABCC9ALDH1A3GABRA1GABRG2
SCHEMBL17704032 0.89 ABCC9 (0.34) ABCC9PGRABCB1
SCHEMBL17704068 0.88 ABCC9 (0.35) MYCABCC9ALDH1A3JAK2PRKD3
SCHEMBL17704002 0.88 MYC (0.41) MYCABCC9ALDH1A3GABRA1GABRG2
SCHEMBL17704027 0.87 CYP11B2 (0.42) ABCC9FLT3CTSDBACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9722187-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2017-08-01 — — US disclosed
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-04-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160118599-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, AOX1, CYP1A1 MYC 389/4885ABCC9 2989/4885ALDH1A3 60/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback